Pulse Biosciences signs new $85M ATM equity program with Mizuho, ends TD Cowen ATM

PULSE BIOSCIENCES, INC.

New equity distribution agreement with Mizuho allows up to $85M in common stock sales; commission up to 3.0%.
As of Sep 14, 2026, 1.38M shares sold under prior Aug 2026 Mizuho ATM, raising ~$68.8M of $75M limit.
Terminated TD Cowen distribution agreement with ~$1.0M unsold; effective Sep 14, 2026.
Sales via at-the-market offerings on Nasdaq under S-3 shelf (File 333-293596) effective Feb 27, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.